Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD
GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD
GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD
Submitted by
admin
on May 1, 2014 - 10:03am
Source:
Marketwatch
News Tags:
GSK
FDA
Incruse Ellipta
COPD
Headline:
GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD
Do Not Allow Advertisers to Use My Personal information
